Our result is consistent with an earlier report describing TLR2 involvement in the proliferation and survival of CD8+ T cells than CD4+ T cells.25 Since CD8+ CTLs are very important in tumor killing,26 we next evaluated the anti‐tumor immunity of SMU‐Z1. The gene discussed is CD4; the disease is neoplasm.